Obese children metabolize drugs differently than healthy weight children

Apr 27, 2010

Researchers from the University of Minnesota College of Pharmacy have provided the first evidence-based data on changes in drug metabolism in obese children as compared to healthy weight children.

The study, conducted by L'Aurelle Johnson and Manoj Chiney in the Department of Experimental and Clinical Pharmacy, evaluated in sixteen healthy weight and nine obese children.

"We have known for years that drugs metabolize differently in obese adults as compared to healthy weight adults," said Johnson. "But, there has been very little, if any, information available that specifically addresses the consequences of obesity on drug metabolism in children. Without this information, our ability to identify optimal drug dosing in children often relies on trial and error approaches."

In the study, Johnson and Chiney examined drug metabolizing enzyme activity in healthy weight and obese children, age 6 to 10 years old. Specifically, they looked at how the children metabolized caffeine and dextromethorphan, a key ingredient in the cough suppressant Robitussin® DM.

They found that metabolized both drugs at different rates than healthy weight children.

Johnson said this finding is the first of many steps in determining the overall effect of obesity on drug absorption, distribution, metabolism and elimination in children. She plans to conduct additional research to define the activity of other drug metabolizing enzymes that may also be altered in the pediatric population as a result of obesity.

"Collectively, such knowledge concerning key factors that impact activity of drug metabolizing enzymes in children will have a significant positive impact on the development of optimal drug dosing regiments in children in order to maximize efficacy, while minimizing potential adverse drug effects, in the treatment of serious diseases such as cancer," said Johnson.

Johnson will present the research, which was funded by the NIH National Center for Research Resources "Multidisciplinary Scholar Development Program" 5K12RR023247, at the American Society for Pharmacology and Experimental Therapeutics annual meeting in a poster titled "The effect of obesity on drug metabolism in African-American children." The presentation will occur on Tuesday April 27 at 12:30 pm PST in Exhibit Hall CD of the Anaheim Convention Center.

Explore further: Ultrasound enhancement provides clarity to damaged tendons, ligaments

add to favorites email to friend print save as pdf

Related Stories

Childhood obesity link to parents

Jul 13, 2009

The relationships between children and their parent of the same gender in the earliest years of life could be the key to understanding why some young people become obese and others do not, new research conducted by the EarlyBird ...

Obesity highest in children from lower income areas

Sep 15, 2008

(PhysOrg.com) -- School children from lower socioeconomic areas are one-and-a-half times more likely to be overweight or obese compared with children living in wealthier areas, a new study has found.

Recommended for you

A better way to track emerging cell therapies using MRIs

Sep 19, 2014

Cellular therapeutics – using intact cells to treat and cure disease – is a hugely promising new approach in medicine but it is hindered by the inability of doctors and scientists to effectively track the movements, destination ...

User comments : 0